Cost Effectiveness of Cetuximab and Panitumumab for First-Line RAS WT Metastatic Colorecal Cancer
Abstract
Authors
I Tikhonova M Hoyle T Snowsill L Crathorne J Varley-Campbell J Peters S Briscoe M Bond N Huxley
I Tikhonova M Hoyle T Snowsill L Crathorne J Varley-Campbell J Peters S Briscoe M Bond N Huxley
ISPOR recommends that you update your browser for more security, speed and the best experience on ispor.org. Update my browser now